Dashboard
Manage Tickers

IMGOImago BioSciences, Inc.

Nasdaq imagobio.com


$ 36.00 $ 0.01 (0.03 %)    

Tuesday, 10-Jan-2023 15:59:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.02 $ -0.13 (-0.03 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 36.01
$ 35.98 x 1,000
$ 36.01 x 1,000
-- - --
$ 11.56 - $ 36.09
139,341
na
1.22B
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-09-2022 09-30-2022 10-Q
2 08-12-2022 06-30-2022 10-Q
3 05-12-2022 03-31-2022 10-Q
4 03-24-2022 12-31-2021 10-K
5 11-10-2021 09-30-2021 10-Q
6 08-19-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-into-imago-biosciencess-recent-short-interest
Looking Into Imago BioSciences's Recent Sh...
01/04/2023 18:02:02

Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently repor...

5-most-expensive-health-care-stocks-you-should-worry-about
5 Most Expensive Health Care Stocks You Sh...
01/03/2023 13:10:47

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

imago-biosciences-announces-first-participant-dosed-in-investigator-sponsored-phase-2-study-of-bomedemstat-in-combination-with-ruxolitinib-in-myelofibrosis
Imago BioSciences Announces First Particip...
12/20/2022 21:10:19

Imago BioSciences, Inc. ("Imago" or the "Company") (NASDAQ:IMGO), a clinical-stage biopharmaceutical company di...

imago-biosciences-presents-data-from-ongoing-phase-2-study-of-bomedemstat-in-advanced-myelofibrosis-at-ash-2022
Imago BioSciences Presents Data From Ongoi...
12/12/2022 15:04:28

Imago BioSciences, Inc. (“Imago”) (NASDAQ:IMGO), a clinical-stage biopharmaceutical company discovering and developing new medi...

Core News & Articles
Merck Begins Tender Offer to Acquire Imago...
12/12/2022 11:45:46

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tende...

how-is-the-market-feeling-about-imago-biosciences
How Is The Market Feeling About Imago BioS...
12/09/2022 15:16:14

Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently repor...

imago-biosciences-announces-first-participant-dosed-in-investigator-sponsored-phase-1-study-of-bomedemstat-in-combination-with-venetoclax-in-relapsedrefractory-acute-myeloid-leukemia
Imago BioSciences Announces First Particip...
11/30/2022 21:24:44

 Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical-stage biopharmaceutical company discovering and developing...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
11/28/2022 15:01:31

analyst-ratings-for-imago-biosciences
Analyst Ratings for Imago BioSciences
11/28/2022 14:00:40

stifel-downgrades-imago-biosciences-to-hold-raises-price-target-to-36
Stifel Downgrades Imago BioSciences to Hol...
11/28/2022 13:44:43

Stifel analyst Stephen Willey downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $...

what-5-analyst-ratings-have-to-say-about-imago-biosciences
What 5 Analyst Ratings Have To Say About I...
11/22/2022 20:01:18

expert-ratings-for-imago-biosciences
Expert Ratings for Imago BioSciences
11/22/2022 16:06:01

amazon-to-119-here-are-5-other-price-target-changes-for-tuesday
Amazon To $119? Here Are 5 Other Price Tar...
11/22/2022 12:48:03

hc-wainwright--co-downgrades-imago-biosciences-to-neutral-raises-price-target-to-36
HC Wainwright & Co. Downgrades Imago BioSc...
11/22/2022 11:11:37

HC Wainwright & Co. analyst Mitchell Kapoor downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Neutral and raises th...

cowen--co-downgrades-imago-biosciences-to-market-perform-announces-36-price-target
Cowen & Co. Downgrades Imago BioSciences t...
11/22/2022 10:31:37

Cowen & Co. analyst Marc Frahm downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Market Perform and announce...

jefferies-downgrades-imago-biosciences-to-hold-raises-price-target-to-36
Jefferies Downgrades Imago BioSciences to ...
11/22/2022 10:21:36

Jefferies analyst Maury Raycroft downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target fro...

why-drive-shack-shares-jumped-over-23-here-are-76-biggest-movers-from-yesterday
Why Drive Shack Shares Jumped Over 23%; He...
11/22/2022 08:49:19

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it ...

nasdaq-down-more-than-100-points-gold-falls-1
Nasdaq Down More Than 100 Points; Gold Fal...
11/21/2022 20:00:05

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.

why-tuanche-shares-are-trading-lower-by-76-here-are-48-stocks-moving-in-mondays-mid-day-session
Why TuanChe Shares Are Trading Lower By 76...
11/21/2022 18:36:11

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the comp...

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
11/21/2022 17:36:31

  During Monday's session, 50 stocks hit new 52-week highs.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION